Baxter: Phase III trial of Von Willebrand Treatment

FOR IMMEDIATE RELEASEMedia Contacts:Deborah Spak, (847) 948-2349 Marie Kennedy, (805) 372-3543Investor Contacts:Mary Kay Ladone, (847) 948-3371 Clare Trachtman, (847) 948-3085BAXTER INITIATES PHASE III TRIAL OF INVESTIGATIONAL BAX 111 FOR THE TREATMENT OF VON WILLEBRAND DISEASEFirst Recombinant Product in Clinical Development for Most Common Inherited Bleeding DisorderDEERFIELD, Ill., OCTOBER 13, 2011 – Baxter International Inc. today […]